LifeMD/$LFMD
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About LifeMD
LifeMD Inc is a direct-to-patient telehealth company that provides a smarter, cost-effective, and more convenient way of accessing comprehensive, virtual healthcare. Its telehealth platform seamlessly integrates a clinician-centric electronic medical record (EMR) system, proprietary algorithms for case-load balancing and scheduling, customer relationship management functionality, remote and in-home lab testing, and digital prescription capabilities, patient-provider audio/video interfacing, cloud pharmacy fulfillment, and more. In addition to telehealth offerings, the company sells nutritional supplements and other over-the-counter products. The company has two operating segments: Telehealth and WorkSimpli. The company generates the majority of its revenue from the Telehealth segment.
Ticker
$LFMD
Sector
Primary listing
Industry
Health Care Technology
Headquarters
Employees
306
ISIN
US53216B1044
Website
LifeMD Metrics
BasicAdvanced
$684M
-
-$0.33
2.23
-
Price and volume
Market cap
$684M
Beta
2.23
52-week high
$15.29
52-week low
$3.99
Average daily volume
1.9M
Financial strength
Current ratio
0.821
Quick ratio
0.732
Long term debt to equity
-3,311.367
Total debt to equity
-6,390.457
Interest coverage (TTM)
-3.19%
Profitability
EBITDA (TTM)
-5.865
Gross margin (TTM)
87.99%
Net profit margin (TTM)
-4.58%
Operating margin (TTM)
-3.18%
Effective tax rate (TTM)
-4.12%
Revenue per employee (TTM)
$760,000
Management effectiveness
Return on assets (TTM)
-6.88%
Return on equity (TTM)
-2,243.07%
Valuation
Price to revenue (TTM)
2.714
Price to book
-281.5
Price to tangible book (TTM)
-35.58
Price to free cash flow (TTM)
10,628.088
Free cash flow yield (TTM)
0.01%
Free cash flow per share (TTM)
0.14%
Growth
Revenue change (TTM)
43.07%
Earnings per share change (TTM)
-55.34%
3-year revenue growth (CAGR)
31.16%
10-year revenue growth (CAGR)
76.23%
3-year earnings per share growth (CAGR)
-47.31%
10-year earnings per share growth (CAGR)
20.28%
What the Analysts think about LifeMD
Analyst ratings (Buy, Hold, Sell) for LifeMD stock.
Bulls say / Bears say
LifeMD's telehealth revenue increased by 60% year-over-year in Q4 2024, indicating strong growth in its core business. (stocktitan.net)
The company launched a GLP-1 Weight Management program in April 2023, which has experienced exponential growth, reaching over 71,000 patient subscribers as of September 30, 2024. (beyondspx.com)
LifeMD is expanding its insurance coverage, aiming to cover 150 million lives by 2025, and launching new products in behavioral and women's health. (seekingalpha.com)
LifeMD's stock has experienced a significant decline, touching a 52-week low at $4.03 amid market challenges. (investing.com)
The company is expected to post a loss of 5 cents per share for the period ending March 31, 2025, indicating ongoing profitability challenges. (tradingview.com)
KeyCorp has lowered its price target for LifeMD from $10.00 to $7.00, reflecting reduced expectations for the stock's performance. (marketbeat.com)
Data summarised monthly by Lightyear AI. Last updated on 7 Jun 2025.
LifeMD Financial Performance
Revenues and expenses
LifeMD Earnings Performance
Company profitability
LifeMD News
AllArticlesVideos
LifeMD to Participate in Two Investor Conferences During June
GlobeNewsWire·2 weeks ago
LifeMD Collaborates with Novo Nordisk to Launch $299 Introductory Bundle for Self-Pay Patients Prescribed Wegovy®
GlobeNewsWire·4 weeks ago
LifeMD to Participate in Three Investor Conferences During May
GlobeNewsWire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for LifeMD stock?
LifeMD (LFMD) has a market cap of $684M as of June 20, 2025.
What is the P/E ratio for LifeMD stock?
The price to earnings (P/E) ratio for LifeMD (LFMD) stock is 0 as of June 20, 2025.
Does LifeMD stock pay dividends?
No, LifeMD (LFMD) stock does not pay dividends to its shareholders as of June 20, 2025.
When is the next LifeMD dividend payment date?
LifeMD (LFMD) stock does not pay dividends to its shareholders.
What is the beta indicator for LifeMD?
LifeMD (LFMD) has a beta rating of 2.23. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.